Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$GlaxoSmithKline (GSK.US)$ Very poor performance stock. Not ...

$GlaxoSmithKline (GSK.US)$ Very poor performance stock. Not suprise in the end of 2024, it will be worth around $25
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
82K Views
Comment
Sign in to post a comment